Evidence map›Paper›PMID 8985357›Full record

ArticleJournal of virology1997

The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.

C Nonkwelo, I K Ruf, J Sample

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

C NonkweloDepartment of Virology and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
I K Ruf
J Sample
Cancer Institute (WIA) · IN

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SUZANNE J. BAKER · 1985 to 2026
$166.9M
Regulation of Epstein Barr Virus PersistenceR01CA056639 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SAMPLE, JEFFERY T · 1992 to 2006
$1.6M
TRAINING IN VIRAL MOLECULAR BIOLOGY AND IMMUNOLOGYT32AI007372 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI WEBSTER, ROBERT G. · 1991 to 2001
$310k
NCI NIH HHS CA-21765NCI NIH HHS CA-56639NIAID NIH HHS T32-AI-07372
6 · The paper itself

Abstract

Expression of the Epstein-Barr virus (EBV) EBNA-1 protein within EBV-positive tumor cells and subpopulations of latently infected B lymphocytes in vivo is mediated by the promoter Qp. Previous studies have established that Qp is a TATA-less promoter whose activation requires only proximal regulatory elements and that it is negatively autoregulated through two EBNA-1 binding sites downstream of the transcription initiation sites. The objective of this study was to better define the properties of an essential positive regulatory element (QRE-2) adjacent to a major transcription start site of Qp and to evaluate the contributions of other potential regulatory elements proximal to the Qp start site. Using DNA affinity purification and UV cross-linking, we have identified the QRE-2-binding protein as a single polypeptide of approximately 40 kDa. The DNA-binding properties of this protein are clearly distinct from those of the TATA-binding protein, suggesting that in the absence of a TATA box, QRE-2 may function as an initiator element to direct assembly of TFIID near the transcription start site. Mutational analysis of potential regulatory elements, furthermore, indicated that the putative E2F binding sites within the EBNA-1 binding domain can exert a positive influence on Qp that is EBNA-1 independent, suggesting that these regulatory elements play an additional if not different role in Qp regulation than previously proposed. A model for the regulation of Qp consistent with the current and previous findings which provides for a simple but efficient mechanism of ensuring the EBNA-1 expression necessary to sustain long-term latency is presented.

Indexed as

Promoter Regions, GeneticRegulatory Sequences, Nucleic AcidBase SequenceDNA-Binding ProteinsDNA, ViralEpstein-Barr Virus Nuclear AntigensHerpesvirus 4, HumanHumansMolecular Sequence DataPeptide Chain Initiation, TranslationalTranscription FactorsTranscription Factor TFIIDDNA-Binding ProteinsDNA, ViralEpstein-Barr Virus Nuclear AntigensTranscription FactorsTranscription Factor TFIID

Identifiers

PMID8985357
PMCPMC191058
OpenAlexW1763440968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.